Join us virtually at the 33rd European Congress of Pathology (ECP) to discuss how to accelerate the adoption of precision oncology in your laboratory. Come and experience why next generation sequencing is the platform of choice for tumour genomic profiling and how you can now do NGS in 1 day with the speed and simplicity of immunohistochemistry.
This year we will have the opportunity to network with you during two exciting symposia. See details below.
Come to our symposia to hear about our speakers’ experiences in delivering NGS genomic profiles in 1 day with the speed and simplicity of immunohistochemistry and how they have maximised their oncology biomarkers testing strategies to analyse current and emerging biomarkers.
Monday, 30th August 2021, 11:45 – 13:15 CEST
In this seminar thought leaders will share their experience in delivering NGS genomic profiles in 1 day with the speed and simplicity of immunohistochemistry and how they have maximised their oncology biomarkers testing strategies to analyse current and
emerging biomarkers.
Dr. Massimo Barberis, Director of Histopathology and Molecular Diagnostics Unit, European Institute of Oncology, Milan, Italy
Dr. Jon Sherlock, Director Product Management, Thermo Fisher Scientific
Dr. Javier Hernandez Losa, Director of Molecular Biology Laboratory, Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain
Dr. Nicola Normanno, Director of Department of Experimental Oncology, INT-Fondazione Pascale, Naples, Italy
Prof. Dr. Peter Wild, Director of Dr. Senckenberg Institute for Pathology, University Hospital Frankfurt, Frankfurt, Germany
Tuesday, 31st August 2021, 6:45 – 7:45 CEST
In this symposium, we will hear about the experience of different laboratories and the strategy they are employing for different biomarker types and clinical research projects.
Dr. Jose Luis Costa, EMEA Medical Affairs Director, Thermo Fisher Scientific
Ilaria Alborelli, PhD,
Clinical Data Analyst, Institute of Pathology and Medical Genetics, University Hospital Basel, Switzerland
Dr. Massimo Barberis, Director of Histopathology and Molecular Diagnostics Unit, European Institute of Oncology, Milan, Italy
The Oncomine Precision Assay on the Ion Torrent Genexus System features a complete next-generation sequencing (NGS) testing workflow. Now every lab can go from sample to report in a single day, providing a comprehensive genomic profile at a speed never possible before. This allows you to deliver NGS results at the same time as other single-gene methods, such as immunohistochemistry (IHC) and PDL1 biomarker test. The hands-off, set-up-and-go workflow makes NGS accessible, even if your lab is new to the technology.
For Research Use only. Not for use in diagnostic procedures.
We've detected your location to be Japan.
Sorry, you cannot access this website. The content on www.oncomine.com is only intended for healthcare professionals. Formore information on our research solutions, please visit ThermoFisher.com
このウェブサイトは、日本国内の医療関係者の方への情報提供を目的としており、一般の方に対する情報提供を目的としたものではないことをご了承ください。研究用製品の情報はThermoFisher.comよりご覧ください。